Literature DB >> 23197382

Regression models for group testing data with pool dilution effects.

Christopher S McMahan1, Joshua M Tebbs, Christopher R Bilder.   

Abstract

Group testing is widely used to reduce the cost of screening individuals for infectious diseases. There is an extensive literature on group testing, most of which traditionally has focused on estimating the probability of infection in a homogeneous population. More recently, this research area has shifted towards estimating individual-specific probabilities in a regression context. However, existing regression approaches have assumed that the sensitivity and specificity of pooled biospecimens are constant and do not depend on the pool sizes. For those applications, where this assumption may not be realistic, these existing approaches can lead to inaccurate inference, especially when pool sizes are large. Our new approach, which exploits the information readily available from underlying continuous biomarker distributions, provides reliable inference in settings where pooling would be most beneficial and does so even for larger pool sizes. We illustrate our methodology using hepatitis B data from a study involving Irish prisoners.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23197382      PMCID: PMC3590921          DOI: 10.1093/biostatistics/kxs045

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  23 in total

1.  Regression models for disease prevalence with diagnostic tests on pools of serum samples.

Authors:  S Vansteelandt; E Goetghebeur; T Verstraeten
Journal:  Biometrics       Date:  2000-12       Impact factor: 2.571

2.  The efficiency of pooling in the detection of rare mutations.

Authors:  J L Gastwirth
Journal:  Am J Hum Genet       Date:  2000-10       Impact factor: 11.025

3.  Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving.

Authors:  Marian J Currie; Michelle McNiven; Tracey Yee; Ursula Schiemer; Francis J Bowden
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

4.  Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures.

Authors:  Albert Vexler; Enrique F Schisterman; Aiyi Liu
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

5.  Deconvolution Estimation in Measurement Error Models: The R Package decon.

Authors:  Xiao-Feng Wang; Bin Wang
Journal:  J Stat Softw       Date:  2011-03-01       Impact factor: 6.440

6.  Pooling nasopharyngeal/throat swab specimens to increase testing capacity for influenza viruses by PCR.

Authors:  Tam T Van; Joseph Miller; David M Warshauer; Erik Reisdorf; Daniel Jernigan; Rosemary Humes; Peter A Shult
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

7.  Cost savings and increased efficiency using a stratified specimen pooling strategy for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Joanna Lynn Lewis; Vivian Marie Lockary; Sadika Kobic
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

8.  Studies of AIDS and HIV surveillance. Screening tests: can we get more by doing less?

Authors:  X M Tu; E Litvak; M Pagano
Journal:  Stat Med       Date:  1994 Oct 15-30       Impact factor: 2.373

9.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.

Authors:  S Allwright; F Bradley; J Long; J Barry; L Thornton; J V Parry
Journal:  BMJ       Date:  2000-07-08

10.  Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism.

Authors:  Michael Schmidt; W Kurt Roth; Hermann Meyer; Erhard Seifried; Michael K Hourfar
Journal:  Transfusion       Date:  2005-03       Impact factor: 3.157

View more
  15 in total

1.  Bayesian regression for group testing data.

Authors:  Christopher S McMahan; Joshua M Tebbs; Timothy E Hanson; Christopher R Bilder
Journal:  Biometrics       Date:  2017-04-12       Impact factor: 2.571

2.  Misclassified group-tested current status data.

Authors:  L C Petito; N P Jewell
Journal:  Biometrika       Date:  2016-12-08       Impact factor: 2.445

3.  Prevalence estimation subject to misclassification: the mis-substitution bias and some remedies.

Authors:  Zhiwei Zhang; Chunling Liu; Sungduk Kim; Aiyi Liu
Journal:  Stat Med       Date:  2014-07-18       Impact factor: 2.373

4.  Group testing case identification with biomarker information.

Authors:  Dewei Wang; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Comput Stat Data Anal       Date:  2018-02-01       Impact factor: 1.681

5.  Capturing the pool dilution effect in group testing regression: A Bayesian approach.

Authors:  Stella Self; Christopher McMahan; Stefani Mokalled
Journal:  Stat Med       Date:  2022-07-25       Impact factor: 2.497

6.  Group testing regression models with dilution submodels.

Authors:  Md S Warasi; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Stat Med       Date:  2017-08-30       Impact factor: 2.373

7.  Hierarchical group testing for multiple infections.

Authors:  Peijie Hou; Joshua M Tebbs; Christopher R Bilder; Christopher S McMahan
Journal:  Biometrics       Date:  2016-09-22       Impact factor: 2.571

8.  Estimating the prevalence of multiple diseases from two-stage hierarchical pooling.

Authors:  Md S Warasi; Joshua M Tebbs; Christopher S McMahan; Christopher R Bilder
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

9.  Modeling and computation of multistep batch testing for infectious diseases.

Authors:  Hongshik Ahn; Haoran Jiang; Xiaolin Li
Journal:  Biom J       Date:  2021-04-19       Impact factor: 1.715

10.  Optimal uses of pooled testing for COVID-19 incorporating imperfect test performance and pool dilution effect: An application to congregate settings in Los Angeles County.

Authors:  Roch A Nianogo; I Obi Emeruwa; Prabhu Gounder; Vladimir Manuel; Nathaniel W Anderson; Tony Kuo; Moira Inkelas; Onyebuchi A Arah
Journal:  J Med Virol       Date:  2021-05-27       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.